Skip to Content

Fortamet FDA Approval History

FDA Approved: Yes (Discontinued) (First approved April 28, 2004)
Brand name: Fortamet
Generic name: metformin
Dosage form: Extended-Release Tablets
Company: Andrx Corporation
Treatment for: Diabetes, Type 2

Marketing Status: Discontinued.

Fortamet (metformin) is an extended-release antihyperglycemic for the treatment of type 2 diabetes.

Development Timeline for Fortamet

Apr 28, 2004Approval FDA Approves Fortamet (metformin HCl) Extended-Release Tablets for Type 2 Diabetes

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.